Our study assessed the feasibility of a novel method for real-time lesion targeting during transrectal in-bore MRI-guided prostate biopsy using a tablet device inside the MR room. Real-time targeting was technically successful in all patients and allowed targeted biopsy of the cancer suspicious region without requiring additional needle guide adjustments in all but one patient. Prostate cancer (PCa) was found in 18 of 20 patients. Our initial clinical experience indicates a substantial decrease in biopsy and procedure time as compared to standard targeting, which could be valuable to increase clinical applicability of the technique.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords